Which DPP-4 inhibitor is listed with the brand name Januvia?

Prepare for the Glucose Management Test with interactive quizzes featuring multiple choice questions, hints, and detailed explanations. Boost your confidence and be exam-ready!

Multiple Choice

Which DPP-4 inhibitor is listed with the brand name Januvia?

Explanation:
Januvia is sitagliptin, a DPP-4 inhibitor. DPP-4 inhibitors work by blocking the enzyme that degrades incretin hormones (like GLP-1 and GIP), which increases glucose-dependent insulin release and suppresses glucagon to help lower blood glucose. Other drugs in this class have different brand names: saxagliptin is Onglyza, linagliptin is Tradjenta, and alogliptin is Nesina. So Januvia corresponds to sitagliptin, not saxagliptin.

Januvia is sitagliptin, a DPP-4 inhibitor. DPP-4 inhibitors work by blocking the enzyme that degrades incretin hormones (like GLP-1 and GIP), which increases glucose-dependent insulin release and suppresses glucagon to help lower blood glucose. Other drugs in this class have different brand names: saxagliptin is Onglyza, linagliptin is Tradjenta, and alogliptin is Nesina. So Januvia corresponds to sitagliptin, not saxagliptin.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy